T. Rowe Price Investment Management, Inc. Avanos Medical, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $164 Billion
- Q3 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Avanos Medical, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 4,713,494 shares of AVNS stock, worth $53.7 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,713,494
Previous 3,996,518
17.94%
Holding current value
$53.7 Million
Previous $48.9 Million
11.39%
% of portfolio
0.03%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding AVNS
# of Institutions
302Shares Held
44.7MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY7.01MShares$79.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$39 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.5MShares$28.5 Million0.44% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.35MShares$26.8 Million0.01% of portfolio
-
Brown Advisory Inc2.23MShares$25.4 Million0.04% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $529M
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...